Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations

CYTOMARK, a non-invasive in vitro diagnostic (IVD) test measuring a defined panel of protein biomarkers in cervical fluid, can accurately detect endometrial cancer in both symptomatic and asymptomatic women at high risk for the disease. The aim of the study consists in validating CYTOMARK's ELISA test, creating and freezing an algorithm detect EC in post-menopausal women with abnormal uterine bleeding (AUB).

NCT Number	NCT07148154
Lead Sponsor	MiMARK Diagnostics, S.L. Collaborators: Hospital Vall d'Hebron
Conditions	Endometrial Cancer
Enrollment	3,000 participants
Start Date	2024-06-24
Primary Completion	2026-09-30 (estimated)
Study Completion	2026-09-30 (estimated)
Updated on ClinicalTrials.gov	2025-08-29